A Randomised Trial of ATRA in a Novel Drug Combination for Pancreatic Cancer

NCT04241276 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

170

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: ATRA
DRUG: Gemcitabine
DRUG: nab-paclitaxel

Sponsor

Queen Mary University of London

Collaborators

[object Object]
[object Object]